Simpler Grants.gov #PAR-26-064

NIH NCI SPORE Grants for Translational Cancer Research (P50 Clinical Trial Required)

The National Institutes of Health (NIH), through the National Cancer Institute (NCI), is seeking applications for P50 SPORE (Specialized Programs of Research Excellence) grants to advance translational cancer research. - Government Buyer: - National Institutes of Health (NIH) - National Cancer Institute (NCI) - Purpose: - Support state-of-the-art, investigator-initiated translational research focused on prevention, early detection, diagnosis, and treatment of organ-specific or closely related cancers - Research must be based on human biology and use cellular, molecular, structural, biochemical, and/or genetic approaches - Projects are required to reach a translational human endpoint within the grant period - Eligibility: - Open to nonprofit organizations, government entities, educational institutions, and businesses - Funding Details: - Total available funding: $25,000,000 - Expected number of awards: 12 - Notable Requirements: - Research must be translational and human-focused - No specific products, OEMs, or vendors are named, as this is a grant for research centers, not a procurement of goods or services

Description

The National Cancer Institute (NCI) invites applications for P50 Research Center Grants for Specialized Programs of Research Excellence (SPORE). The program funds translational research aimed at improving prevention, early detection, diagnosis, and treatment of organ-specific cancers or highly related groups of cancers. Research must be translational and based on human biology using various experimental approaches, with the goal of reaching a translational human endpoint within the grant period. Eligible applicants include a wide range of nonprofit, government, education, and business entities.

View original listing